Trademark: 88223219
Word
JP JAZZ PHARMACEUTICALS
Status Date
Tuesday, December 17, 2019
Registration Number
5935365
Registration Date
Tuesday, December 17, 2019
Filing Date
Monday, December 10, 2018
Published for Opposition
Tuesday, October 1, 2019
5 House mark for a line of pharmaceuticals for the treatment, management and prevention of cancer, psychiatric diseases and disorders, central nervous system conditions, sleep disorders, narcolepsy, schizophrenia, cataplexy, obstructive sleep apnea, and for use in oncological and hematological diseases and disorders; Pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for use in oncology and hematology; pharmaceutical preparations for the treatment and management of neurological, psychiatric, and sleep conditions, diseases, and disorders; pharmaceutical preparations for the treatment and management of cancer, cataplexy, excessive daytime sleepiness, liver disease, narcolepsy, obstructive sleep apnea, and schizophrenia
The mark consists of "JAZZ PHARMACEUTICALS" positioned to the right of a circular logo with a stylized depiction of the letters "JP" which vertically splits the circle.
JAZZ PHARMACEUTICALS JAZZ PHARMACEUTICALS
Color is not claimed as a feature of the mark.
"PHARMACEUTICALS"
May 26, 2021
Assignment Of Ownership Not Updated Automatically
Dec 17, 2019
Registered-Principal Register
Oct 1, 2019
Official Gazette Publication Confirmation E-Mailed
Oct 1, 2019
Published For Opposition
Sep 11, 2019
Notification Of Notice Of Publication E-Mailed
Aug 27, 2019
Approved For Pub - Principal Register
Aug 2, 2019
Teas/Email Correspondence Entered
Aug 1, 2019
Correspondence Received In Law Office
Aug 1, 2019
Teas Response To Office Action Received
Jun 15, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 15, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 25, 2019
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 25, 2019
Teas Change Of Owner Address Received
Mar 15, 2019
Combined Examiner's Amendment/Priority Action Entered
Mar 15, 2019
Assigned To Lie
Mar 14, 2019
Notification Of Examiner's Amendment/Priority Action E-Mailed
Mar 14, 2019
Examiner's Amendment/Priority Action E-Mailed
Mar 14, 2019
Examiners Amendment And/Or Priority Action - Completed
Mar 7, 2019
Assigned To Examiner
Jan 3, 2019
Notice Of Design Search Code E-Mailed
Jan 2, 2019
New Application Office Supplied Data Entered
Dec 13, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
